Fresenius Medical Care
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 3.7 million patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
See below for the Latest Fresenius Medical Care News, Analysis, Profit Results, Share Price Information, and Commentary.
Asian Experience Awards 2023 Winner: Fresenius Medical Care Pte Ltd
Asian Experience Awards 2023 Winner: Fresenius Medical Care Pte Ltd
Dive into the future of dialysis with Karen Ng, Business Director, and Anbu Srinivasan, Managing Director of Fresenius Medical Care for their notable AR and VR technologies.
Fresenius Medical Care Pte Ltd elevates healthcare training with innovative augmented reality experience
The company was honoured at the Asian Experience Awards 2023 in the Singapore Product Experience of the Year - Health Products & Services category.
Most Read
1. Singapore digital economy surges to $144.1b, now 19% of GDP 2. Stablecoin payments are going mainstream. Hong Kong and APAC are showing how 3. Only 9% of Singapore online shoppers qualify as savvy, report says 4. Why digital assets are set to become mainstream in APAC 5. Rethinking fleet ownership in a changing business landscapeResource Center
Read Here
Advertise
Sign Up
Awards
Nov
11
Feb
23
Event News
The healthcare provider earned recognition for its physical clinic expansion and digital platform enhancements.
Commentary
Rethinking fleet ownership in a changing business landscape
Stablecoin payments are going mainstream. Hong Kong and APAC are showing how
Why regional collaboration is essential for Asia’s next wave of innovation
Why digital assets are set to become mainstream in APAC
Bitcoin’s latest hacks expose where trust really sits in Asia
We're getting very good at the business we're trying to escape
The hidden role of gold nanoparticles in Southeast Asian diagnostics
How homegrown brands are redefining premium in Asia
Why AI sovereignty is a practical discipline for Southeast Asia’s scaleups
Why healthcare must solve for patient behaviour, not just treatment